"10.1371_journal.pone.0109081","plos one","2014-10-02T00:00:00Z","Isabel Fern√°ndez-Pisonero; Javier L√≥pez; Esther Onecha; Ana I Due√±as; Patricia Maeso; Mariano S√°nchez Crespo; Jos√© Alberto San Rom√°n; Carmen Garc√≠a-Rodr√≠guez","Instituto de Biolog√≠a y Gen√©tica Molecular (CSIC-Universidad Valladolid), Valladolid, Spain; Cardiology Department, Instituto Ciencias del Coraz√≥n (ICICOR) Hospital Cl√≠nico Universitario, Valladolid, Spain; Research Unit, Hospital Cl√≠nico Universitario, Valladolid, Spain","Conceived and designed the experiments: CGR JASR MSC. Performed the experiments: IFP JL EO PM AD. Analyzed the data: CGR IFP JL EO. Contributed reagents/materials/analysis tools: JASR JL. Wrote the paper: CGR. Proofread the manuscript and gave advice on the manuscript structure: MSC JASR JL.","The International Patent Aplication WO2012123613, entitled ‚ÄúInhibitors of S1P receptor for the treatment of calcific aortic stenosis‚Äù was published on Sept 20th 2012. Inventors: CGR, MSC, JASR. The patent claims the use of at least one inhibitor of a receptor of sphingosine-1-phosphate for the preparation of a medicament for the prevention and / or treatment of calcific aortic stenosis, but no drug design/development was involved. There has not been any commercial interest for the exploitation of that invention. The foresaid patent application has been deemed to be withdrawn by the applicants, it is currently under public domain, and is apt to be put into practice freely (http://www.google.com/patents/WO2012123613A1?cl=en). No products development, nor consultancy, nor employment has been related with the foresaid patent. This does not alter the authors adherence to all PLOS ONE policies on sharing data and materials.","2014","10","Isabel Fern√°ndez-Pisonero","IF√P",8,TRUE,3,5,4,1,TRUE,TRUE,FALSE,0,NA,FALSE
